Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Haematologica|June 10, 2021
Inhibitors of ADAM10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effectRoberta Pece, Sara Tavella, Delfina Costa, et al.International Journal of Cancer|August 6, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.Leukemia & Lymphoma|September 14, 2004
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study groupGino Santini, Teodoro Chisesi, Sandro Nati, et al.Molecular Medicine (Cambridge, Mass.)|March 12, 2020
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approachMonica Colombo, Davide Bagnara, Daniele Reverberi, et al.Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.Scientific Reports|March 1, 2019
Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyGuido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.Scientific Reports|September 23, 2018
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Guido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.Haematologica|August 29, 2020
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokinesPaolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.Frontiers in Immunology|November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK CellsFabio Guolo, Paola Minetto, Silvia Pesce, et al.Pageof 5